Sarepta Therapeutics Stock Plunges as Second Patient Dies Taking Its Drug

investopedia.com/sarepta-therapeutics-stock-plunges-as-second-patient-dies-taking-its-drug-11755141

Key Takeaways
- Sarepta Therapeutics shares sank to their lowest level in nine years Monday after a second patient taking its Elevidys drug died.
- The patient was being treated for Duchenne muscular dystrophy, and died of acute liver failure.
- In March, the biotech firm announced…

This story appeared on investopedia.com, 2025-06-16 15:37:19.119000.
The Entire Business World on a Single Page. Free to Use →